GlaxoSmithKline (GSK) Tops Q3 EPS by 1c

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of GBP0.33, GBP0.01 better than the analyst estimate of GBP0.32. Revenue for the quarter came in at GBP7.84 billion versus the consensus estimate of GBP7.86 million.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Reading (RDI) Tops Q2 EPS by 4c